Is ABBV up or down today?
ABBV is down 2.05% today, last at 288.84. This stock moved -2.05% versus the prior close.
ABBV · AbbVie
ABBV (AbbVie) is trading at 288.84, down 2.05% on the session. ABBV sits at the 91% mark of its 52-week range, carries a 14-day RSI of 62, and trades above its 50-day average. Over the past month it is up 9.90%.
Leading the coverage: “ABBV Maintains Outperform Rating -- Price Target Raised to $342 - GuruFocus” (Google News, 8h ago).
ABBV trades on a trailing P/E of 82.6 and is running 12.18% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
ABBV is down 2.05% today, last at 288.84. This stock moved -2.05% versus the prior close.
Leading the coverage: “ABBV Maintains Outperform Rating -- Price Target Raised to $342 - GuruFocus” (Google News, 8h ago). Dominant story: ABBV Maintains Outperform Rating -- Price Target Raised to $342 - GuruFocus (3 sources, bullish) RSI is 62 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
ABBV Maintains Outperform Rating -- Price Target Raised to $342 - GuruFocus
ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continues
ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continues - Yahoo Finance
AbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another Test - MarketBeat
AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition